Ethical AI and trustworthy AI frameworks should be table stakes for healthcare and life sciences organizations seeking to innovate with AI. The post From Ethics to Trust: Strategic Guardrails for Safe, Secure, Effective AI in Healthcare appeared first on MedCity News.

The products that succeed over time are usually the ones that make life easier, fit naturally into existing routines and continue delivering value long after the novelty wears off. The post Beyond Adoption: The Habits Shaping Digital Health appeared first on MedCity News.

Sentara Health notified Anthem that it will let its commercial, Medicare and Medicaid contracts expire at year’s end unless the two sides reach a new rate agreement. The dispute puts coverage for an estimated 380,000 Virginians at risk. The post ‘We’re Not Going to Be Bullied’: Sentara Digs in on Anthem Contract Fight  appeared first on MedCity News.

Apnimed will apply the IPO proceeds toward the regulatory process and launch plans of Oxnimbi, a once-nightly pill developed for obstructive sleep apnea. This drug is under FDA review with a February 2027 target date for a regulatory decision. The post Apnimed’s IPO Bags $192M for What Could Become the First Oral Sleep Apnea Drug appeared first on MedCity News.

Health tech companies made several major funding announcements in July. Here is a list of some of the biggest funding rounds. The post 4 Notable Health Tech Funding Announcements in July appeared first on MedCity News.

The future of value-based care will hinge on empowering providers, and specialists in particular, with the data and strategic partnerships to proactively manage patient health beyond traditional clinical settings. The post The Next Phase of Value-Based Care: Why Specialty-Led Models Will Define the Future of Healthcare appeared first on MedCity News.

Hope is a catalyst for scientific ambition. It encourages researchers, clinicians, investors, and innovators to pursue solutions where none currently exist. In oncology, many major breakthroughs begin with the belief that a better answer is possible. The post ​Hope Is Not a Soft Concept, It’s a Strategic Imperative in Cancer Innovation appeared first on MedCity News.

July has seen a slew of executive hires, exits and layoffs across the healthcare industry. For instance, Aledade, Providence and Whoop named new executives. There were also layoffs at organizations including Novartis, Adventist Health and Wellstar Health System. The post Healthcare Moves: A Monthly Summary of Hires, Exits and Layoffs appeared first on MedCity News.

Grove AI’s technology uses voice agents to recruit eligible patients for clinical trials. Formed in 2024, the startup’s rapid growth led to its acquisition by Hippocratic AI earlier this year. The post Startup to Acquisition in 2 Years: Grove AI’s Journey to Transform Clinical Trials appeared first on MedCity News.

Daffodil Health launched an AI-powered solution to help payers manage No Surprises Act disputes by automating claims review, negotiations and arbitration workflows. The post Daffodil Health Launches No Surprises Act Dispute Management Solution appeared first on MedCity News.

Caring for patients with ADHD, or those who potentially have ADHD, extends far beyond diagnosis and prescribing. The post The Battles We Face: ADHD From A Patient Perspective, And What Providers Should Know appeared first on MedCity News.

What healthcare needs now is a connected, deeply integrated system of action that works with the system of record to complete work across the enterprise, supported by accountable partners willing to stand behind the outcomes they create. The post Three Ways Distressed Healthcare Must Evolve appeared first on MedCity News.

Function Health raised $450 million in growth financing from General Catalyst’s Customer Value Fund, just eight months after its $298 million Series B. The lab-testing startup plans to use the capital to expand access to its testing and imaging services. The post Why General Catalyst Is Betting $450M on Function Health’s Preventive Care Push appeared first on MedCity News.

MedCity News’ new event for healthcare investors and corporate business development leads — Bullseye — hit the mark when it comes to provocative and thoughtful commentary. Here’s what was said in panels throughout the day. The post We Are Rats; If Pharma Could Be Brave … And Other Bullseye POVs You Won’t Hear at Other Events appeared first on MedCity News.

The FTC and the states of Utah and California sued Hims & Hers, alleging it improperly shared consumers’ health information and misled customers about billing, subscriptions and cancellations. The post Why Hims & Hers Is Embroiled in Yet Another Controversy, This Time with the FTC appeared first on MedCity News.